150 related articles for article (PubMed ID: 30561502)
1. 3-Bromopyruvate Attenuates Experimental Pulmonary Hypertension via Inhibition of Glycolysis.
Zhang YL; Zhang R; Shen YF; Huang KY; He YY; Zhao JH; Jing ZC
Am J Hypertens; 2019 Mar; 32(4):426-432. PubMed ID: 30561502
[TBL] [Abstract][Full Text] [Related]
2. 3-Bromopyruvate reverses hypoxia-induced pulmonary arterial hypertension through inhibiting glycolysis: In vitro and in vivo studies.
Chen F; Wang H; Lai J; Cai S; Yuan L
Int J Cardiol; 2018 Sep; 266():236-241. PubMed ID: 29735421
[TBL] [Abstract][Full Text] [Related]
3. 3-Bromopyruvate alleviates the development of monocrotaline-induced rat pulmonary arterial hypertension by decreasing aerobic glycolysis, inducing apoptosis, and suppressing inflammation.
Liu J; Wang W; Wang L; Qi XM; Sha YH; Yang T
Chin Med J (Engl); 2020 Jan; 133(1):49-60. PubMed ID: 31923104
[TBL] [Abstract][Full Text] [Related]
4. 3-Bromopyruvate ameliorates pulmonary arterial hypertension by improving mitochondrial metabolism.
Guo Y; Liu X; Zhang Y; Qiu H; Ouyang F; He Y
Life Sci; 2020 Sep; 256():118009. PubMed ID: 32603819
[TBL] [Abstract][Full Text] [Related]
5. 3-Bromopyruvate decreased kidney fibrosis and fibroblast activation by suppressing aerobic glycolysis in unilateral ureteral obstruction mice model.
Yu H; Zhu J; Chang L; Liang C; Li X; Wang W
Life Sci; 2021 May; 272():119206. PubMed ID: 33577854
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of energy-producing pathways of HepG2 cells by 3-bromopyruvate.
Pereira da Silva AP; El-Bacha T; Kyaw N; dos Santos RS; da-Silva WS; Almeida FC; Da Poian AT; Galina A
Biochem J; 2009 Feb; 417(3):717-26. PubMed ID: 18945211
[TBL] [Abstract][Full Text] [Related]
7. Apoptosis-inducing antitumor efficacy of hexokinase II inhibitor in hepatocellular carcinoma.
Kim W; Yoon JH; Jeong JM; Cheon GJ; Lee TS; Yang JI; Park SC; Lee HS
Mol Cancer Ther; 2007 Sep; 6(9):2554-62. PubMed ID: 17876052
[TBL] [Abstract][Full Text] [Related]
8. Effect of the antitumoral alkylating agent 3-bromopyruvate on mitochondrial respiration: role of mitochondrially bound hexokinase.
Rodrigues-Ferreira C; da Silva AP; Galina A
J Bioenerg Biomembr; 2012 Feb; 44(1):39-49. PubMed ID: 22322891
[TBL] [Abstract][Full Text] [Related]
9. 3-bromopyruvate and sodium citrate target glycolysis, suppress survivin, and induce mitochondrial-mediated apoptosis in gastric cancer cells and inhibit gastric orthotopic transplantation tumor growth.
Wang TA; Zhang XD; Guo XY; Xian SL; Lu YF
Oncol Rep; 2016 Mar; 35(3):1287-96. PubMed ID: 26708213
[TBL] [Abstract][Full Text] [Related]
10. 3-Bromopyruvate regulates the status of glycolysis and BCNU sensitivity in human hepatocellular carcinoma cells.
Sun X; Sun G; Huang Y; Hao Y; Tang X; Zhang N; Zhao L; Zhong R; Peng Y
Biochem Pharmacol; 2020 Jul; 177():113988. PubMed ID: 32330495
[TBL] [Abstract][Full Text] [Related]
11. Genistein, a phytoestrogen, attenuates monocrotaline-induced pulmonary hypertension.
Homma N; Morio Y; Takahashi H; Yamamoto A; Suzuki T; Sato K; Muramatsu M; Fukuchi Y
Respiration; 2006; 73(1):105-12. PubMed ID: 16432296
[TBL] [Abstract][Full Text] [Related]
12. Enhanced antitumor activity of 3-bromopyruvate in combination with rapamycin in vivo and in vitro.
Zhang Q; Pan J; Lubet RA; Komas SM; Kalyanaraman B; Wang Y; You M
Cancer Prev Res (Phila); 2015 Apr; 8(4):318-26. PubMed ID: 25644152
[TBL] [Abstract][Full Text] [Related]
13. Thymoquinone attenuates monocrotaline-induced pulmonary artery hypertension via inhibiting pulmonary arterial remodeling in rats.
Zhu N; Zhao X; Xiang Y; Ye S; Huang J; Hu W; Lv L; Zeng C
Int J Cardiol; 2016 Oct; 221():587-96. PubMed ID: 27420584
[TBL] [Abstract][Full Text] [Related]
14. Anti-cancer agent 3-bromopyruvate reduces growth of MPNST and inhibits metabolic pathways in a representative in-vitro model.
Linke C; Wösle M; Harder A
BMC Cancer; 2020 Sep; 20(1):896. PubMed ID: 32948135
[TBL] [Abstract][Full Text] [Related]
15. miR-125a-5p inhibits glycolysis by targeting hexokinase-II to improve pulmonary arterial hypertension.
Luo L; Xiao L; Lian G; Wang H; Xie L
Aging (Albany NY); 2020 May; 12(10):9014-9030. PubMed ID: 32427576
[TBL] [Abstract][Full Text] [Related]
16. [Expression of hexokinase-II gene in human colon cancer cells and the therapeutic significance of inhibition thereof].
Peng QP; Liang HJ; Zhou Q; Zhou JM; Fu XL; Zhong DP
Zhonghua Yi Xue Za Zhi; 2007 Apr; 87(15):1058-62. PubMed ID: 17672972
[TBL] [Abstract][Full Text] [Related]
17. Baicalein attenuates monocrotaline-induced pulmonary arterial hypertension by inhibiting vascular remodeling in rats.
Shi R; Wei Z; Zhu D; Fu N; Wang C; Yin S; Liang Y; Xing J; Wang X; Wang Y
Pulm Pharmacol Ther; 2018 Feb; 48():124-135. PubMed ID: 29133079
[TBL] [Abstract][Full Text] [Related]
18. Role of epidermal growth factor inhibition in experimental pulmonary hypertension.
Dahal BK; Cornitescu T; Tretyn A; Pullamsetti SS; Kosanovic D; Dumitrascu R; Ghofrani HA; Weissmann N; Voswinckel R; Banat GA; Seeger W; Grimminger F; Schermuly RT
Am J Respir Crit Care Med; 2010 Jan; 181(2):158-67. PubMed ID: 19850946
[TBL] [Abstract][Full Text] [Related]
19. Separate and concurrent use of 2-deoxy-D-glucose and 3-bromopyruvate in pancreatic cancer cells.
Xiao H; Li S; Zhang D; Liu T; Yu M; Wang F
Oncol Rep; 2013 Jan; 29(1):329-34. PubMed ID: 23076497
[TBL] [Abstract][Full Text] [Related]
20. The phosphodiesterase-5 inhibitor vardenafil reduces oxidative stress while reversing pulmonary arterial hypertension.
Fan YF; Zhang R; Jiang X; Wen L; Wu DC; Liu D; Yuan P; Wang YL; Jing ZC
Cardiovasc Res; 2013 Aug; 99(3):395-403. PubMed ID: 23650288
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
